Cambridge drugmaker wins city approval to put its sign above the treeline
The Cambridge drugmaker received approval on Thursday night from the city's Board of Zoning Appeal to display its name on a ...
FiercePharma2d
After Moderna's pediatric RSV vaccine trial hold, expert panel says more testing is needed
Two days after the FDA revealed that it had halted enrollment in trials of respiratory syncytial virus (RSV) vaccines that ...
Moderna Inc. stock underperforms Friday when compared to competitors
Shares of Moderna Inc. MRNA slipped 2.31% to $41.83 Friday, on what proved to be an all-around mixed trading session for the ...
BioSpace2d
FDA Committee Calls For More Research After Moderna’s RSV Vaccine Safety Issues
Following news of RSV lower respiratory tract infections in infants immunized with Moderna’s investigational RNA vaccines, ...
Moderna Inc. stock outperforms competitors despite losses on the day
Shares of Moderna Inc. MRNA sank 0.09% to $42.82 Thursday, on what proved to be an all-around dismal trading session for the ...
Yahoo2d
Is Moderna Stock A Sell In December 2024 With Deep Losses Projected For The Fourth Quarter?
Moderna stock remains under pressure with analysts projecting steep losses in the fourth quarter. Is MRNA stock a sell in ...
Unpacking the Latest Options Trading Trends in Moderna
If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.
The specter of RFK Jr. has investors fretting about a onetime vaccine wunderkind
In the chaotic early days of the pandemic, Wall Street scrambled to place bets on the companies that looked the most likely ...
BioPharma Dive2d
FDA panel seeks more data on RSV vaccine safety in infants
After several severe RSV cases were reported in a pediatric trial of Moderna's vaccine, the FDA has partially paused testing ...
MicroStrategy, Palantir added to Nasdaq 100, with Moderna facing an exit
MicroStrategy Inc, the dot-com-era software maker whose metamorphosis into a leveraged bet on bitcoin has transfixed Wall ...
Investor's Business Daily on MSN4h
Palantir, MicroStrategy Likely To Join Nasdaq 100; Will Moderna, Super Micro Get The Axe?
Palantir and bitcoin play MicroStrategy are expected to get a Nasdaq 100 index invite Friday. Will Moderna and Super Micro ...
BofA downgrades Moderna, says it's 'tough time' to be vaccine maker
Moderna (MRNA) shares tumble after Bank of America analysts reinstated its Underperform rating for the stock. In a broader note about the pharmaceutical and biotech spaces, Bank of America's team it's ...